As previously observed (12), a greater frequency of effector-memory (EM) CD4+ T cells was observed in tumors than in NSCLC NT sites or in blood from healthy donors (HD) (Supplementary Figure 7). The gene discussed is CD4; the disease is non-small cell lung carcinoma.